In patients, particularly males with CAPA, levels of IL-8 and caspase-3 can be significantly lower, both of which are usually elevated in patients with IA, COVID-19 and the inability to muster a sufficient response may indicate a risk for developing IA during COVID-19 infection (61). The gene discussed is CXCL8; the disease is episodic ataxia type 2.